{"nct_id":"NCT02168686","title":"Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) Deficiency","status":"COMPLETED","status_verified_date":"2023-09","start_date":"2017-11-28","start_date_type":"ACTUAL","primary_completion_date":"2019-08-29","primary_completion_date_type":"ACTUAL","completion_date":"2019-08-29","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["ADVM"]}